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A B S T R A C T
The need for new approaches to investigate ex vivo the causes and effects of tumor and to achieve improved
cancer treatments and medical therapies is particularly urgent for malignant pathologies such as lymphomas and
leukemias, whose tissue initiator cells interact with the stroma creating a three-dimensional (3D) protective envi-
ronment that conventional mono- and bi-dimensional (2D) models are not able to simulate realistically. The sol-
vent-casting particulate leaching (SCPL) technique, that is already a standard method to produce polymer-based
scaffolds for bone tissue repair, is proposed here to fabricate innovative 3D porous structures to mimic the bone
marrow niche in vitro. Two different polymers, namely a rigid polymethyl methacrylate (PMMA) and a flexible
polyurethane (PU), were evaluated to the purpose, whereas NaCl, in the form of common salt table, resulted to
be an efficient porogen. The adoption of an appropriate polymer-to-salt ratio, experimentally defined as 1:4 for
both PMMA and PU, gave place to a rich and interconnected porosity, ranging between 82.1vol% and 91.3vol%,
and the choice of admixing fine-grained or coarse-grained salt powders allowed to control the final pore size. The
mechanical properties under compression load were affected both by the polymer matrix and by the scaffold's
architecture, with values of the elastic modulus indicatively varying between 29kPa and 1283kPa. Preliminary
tests performed with human stromal HS-5 cells co-cultured with leukemic cells allowed us to conclude that stro-
mal cells grown associated to the supports keep their well-known protective and pro-survival effect on cancer
cells, indicating that these devices can be very useful to mimic the bone marrow microenvironment and there-
fore to assess the efficacy of novel therapies in pre-clinical studies.
1. Introduction
The conventional approach to develop therapies against cancer
makes use of bi-dimensional (2D) tissue cultures, where tumor cells
are seeded, grown and tested on mono- and bi-dimensional substrata.
Even if their complexity greatly depends on their objectives, such mod-
els often fail to reproduce the micro-environment existing in vivo, that
is instead an evolving and three-dimensional structure [1–4]. On the
other hand, animal models, besides requiring specific facilities and pos-
ing ethical concerns, often provide a limited understanding of the in-
dividual steps of the metastatic process and suffer from a problem-
atic determination of quantitative mechanistic data
[4,5]. The inadequacy of standard methods is particularly striking for
malignant pathologies such as leukemias and lymphomas, whose tissue
initiator cells interact with the stroma creating a protective niche re-
sponsible for frequent relapse and drug resistance phenomena. To over-
come these limitations, alternative approaches are emerging that rely
on new biocompatible materials and modern technologies to fabricate
three-dimensional (3D) structures able to simulate in vitro the compli-
cated and intrinsically tridimensional microenvironment existing in vivo,
thus supporting the comprehension of the causes and effects of cancer
and the development of more effective therapies [6–11].
The present contribution proposes highly porous polymer scaffolds
to mimic the bone marrow niche for blast cell culture. The scaf
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Table 1
Experimental details for SCPL scaffolds. S1 stands for NaCl (Sigma-Aldrich), NHC for
NaHCO⁠3 (Sigma-Aldrich), S2 for NaCl (Italkali, fine grained), and S3 for NaCl (Italkali,
coarse grained).
Sample
Polymer
matrix Salt
Polymer-to-salt
wt. ratio
Preliminary samples
PMMA_S1_1:2 PMMA S1 1:2
PMMA_NHC_1:2 PMMA NHC 1:2
PMMA_S1+NHC_1:2 PMMA S1+NHC (50/
50)
1:2
PMMA_S1_1:3 PMMA S1 1:3
PMMA_S2-NS_1:3 PMMA S2-NS (S2, Not
Sieved)
1:3
PMMA_S3-NS_1:3 PMMA N3-NS (S3, Not
Sieved)
1:3
Optimized samples
PMMA_S2 PMMA S2 (sieved) 1:4
PMMA_S3 PMMA S3 (sieved) 1:4
PU_S2 PU S2 (sieved) 1:4
PU_S3 PU S3 (sieved) 1:4
folds were produced by means of the solvent casting particulate-leach-
ing (SCPL) technique, that is currently very popular to fabricate poly-
mer scaffolds for bone tissue engineering. In principle, the polymer is
dissolved in an appropriate solvent and then an insoluble salt is ad-
mixed with the polymer solution. The solvent evaporation gives place
to a salt-polymer composite, which is eventually washed to remove
the salt particles. The SCPL method was chosen because it is rela-
tively simple and straightforward, without the need for specific and
expensive equipment; moreover, it allows to control the final poros-
ity, pore size and interconnectivity by means of a proper selection
of the polymer, of the porogen and of their relative amounts [12].
A recent development of the SCPL technique has demonstrated
that, if the polymer solution is diffused in a steady salt stack and an
appropriate thermal treatment is performed before leaching, even the
crystallinity of the porous foam can be controlled closely [13]. How-
ever, in spite of its easiness and flexibility, so far the SCPL technique has
been rarely applied to fabricate 3D supports for cancer research [14]
and, to the best of the Authors' knowledge, this is the first time it is
specifically exploited to reproduce the bone marrow microenvironment
ex vivo. The present research encompasses therefore the development of
finalized SCPL scaffolds, obtained from a rigid polymethyl methacrylate
(PMMA) and from a flexible polyurethane (PU), and analyzes the ef-
fect of the fabrication conditions on the microstructure, on the mechan-
ical behavior and on the mimicry of the final scaffolds. Nowadays other
synthetic polymers, such as polycaprolactone (PCL) and poly(α‑hydroxy
acids), including PGA, PLA, and their copolymer PLGA, are most com-
monly used as scaffolding materials in tissue engineering on account of
their biodegradability. In fact, they are designed on purpose to degrade
in-vivo and to be replaced gradually by the healing bone tissue [15,16].
However, in the present context non-biodegradable polymers should be
applied instead, because they are expected to remain unchanged upon
cell culturing and therapy assessment. Preference was given to PMMA
and PU due to their promising potentialities. Even if it is conventionally
used as self-hardening cement for orthopedic implant fixation rather
than as scaffolding material in bone tissue engineering, PMMA is an in-
teresting candidate for the production of substrates for cell culturing on
account of its good biocompatibility characteristics (solid PMMA is an
FDA approved implant material) and relatively high elastic modulus up
to approximately 2GPa [17].
Polyurethanes have a segmented molecular structure including di-
or poly-isocyanates (hard segments) and di- or poly-ols (soft segments),
which makes it possible to control their physical and mechanical prop-
erties on a wide range, depending on the composition
Fig. 1. Salt particles: S1 (a), NHC (b), S2 after sieving (c) and S3 after sieving (d). Scale bar: 1mm.
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Fig. 2. Pilot SCPL scaffolds in PMMA: PMMA_S1_1:2 (a), PMMA_NHC_1:2 (b), and PMMA_S1+NHC_1:2 (c). Scale bar: 1mm.
and the synthesis procedure that is applied. They are characterized by
biocompatibility and moderate compatibility with blood and, though
originally addressed to artificial skin, vascular grafts, neural connec-
tions, and articular cartilage reconstruction applications, they are now
emerging also as suitable scaffolding materials [18,19].
2. Materials and methods
2.1. Preparation of SCPL scaffolds
Two different polymers were compared for the matrix, namely
poly(methyl methacrylate), “PMMA” (Optix CA-1000 I, Optix Acrylic
Resins, Plaskolite Inc. Columbus, Ohio, U.S.A.; properties available
on-line [20]), and polyurethane, “PU” (Z1A1, Biomer Technology Ltd.,
Cheshire, England; properties available on-line [21]). Both polymers
were used as received, without any purification prior to scaffold fabri-
cation.
The research included the production of preliminary samples, to de-
termine the effect of the processing conditions, and the fabrication and
subsequent characterization of the optimized scaffolds. PMMA was the
matrix for all the preliminary samples, which were produced and an-
alyzed to assess the role of the salt type, of the salt particle size and
of the polymer-to-salt ratio. In order to create the porosity, various
salts were compared, including NaCl, hereafter “S1” (Sigma-Aldrich,
CAS number 7614-14-5), NaHCO⁠3, “NHC” (Sigma-Aldrich, CAS number
144-55-8), as well as fine-grained and coarse-grained marine NaCl for
dietary use (Italkali Società Italiana Sali Alcalini S.p.A.). For the pre-
liminary samples, the marine NaCl salts were used as received, with-
out sieving (for these “not sieved” salts, the labels “S2-NS” and “S3-NS”
were used to indicate the fine-grained powder and the coarse-grained
one, respectively); for the optimized samples, instead, the fine-grained
salt was sieved below 1000μm (=1mm),
whereas the coarse-grained salt was sieved between 1000μm (=1mm)
and 2000μm (=2mm); for these sieved salts, the names “S2” and “S3”
were adopted for simplicity.
Tetrahydrofuran, “THF” (Analar Normapur (VWR), CAS 109-99-9),
was employed to dissolve the PMMA granules, whereas a 50-50 mixture
of N,N‑dimethylformamide, “DMF” (Sigma, CAS Number 68-12-2), and
of THF was used for PU.
In the general procedure, the polymer was dissolved in the ap-
propriate medium (PMMA in THF, typical concentration: 20g PMMA/
100ml THF; PU in DMF+THF, typical concentration: 12g PU/100ml
DMF+THF); the salt was added to the polymer solution according to a
prefixed polymer-to-salt ratio and stirred until uniformly dispersed; the
dispersion was poured into silicon moulds. The solvent was left to evap-
orate overnight, then the samples were extracted from the moulds and
generously rinsed with distilled water, to start removing the salt. The
samples were soaked in distilled water for a week, replacing the wa-
ter twice a day; to conclude they were sonicated in distilled water for
30min and left to dry in ambient conditions. Table 1 lists all the sam-
ples with the corresponding experimental details.
2.2. Characterization
The salt particles for SCPL as well as the scaffolds were observed
with an environmental scanning electron microscope, “ESEM” (FEI
Quanta, The Netherlands), operated in high vacuum mode, for the salts,
or in low vacuum mode, for the scaffolds (0.68bar).
The granulometric size distribution of the salt particles used for
the optimized SCPL scaffolds (namely S2 and S3 sieved marine salts)
was determined with a laser granulometer (Mastersizer 2000 Ver. 5.22,
Malvern Instruments Ltd., Malvern, UK); the salts were dispersed in
ethanol (Baker, CAS number: 64-17-5).
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Fig. 3. Pilot SCPL scaffolds in PMMA: PMMA_S1_1:3 (a), PMMA_S2-NS_1:3 (b), and PMMA_S3-NS_1:3 (c). Scale bar: 1mm.
The Fourier transform infrared spectroscopy, “FT-IR” (FTIR VERTEX
70), was carried out on the original polymers, as well as on the scaf-
folds, working under the attenuated total reflection (ATR) mode, in
the 4000cm⁠−1–600cm⁠−1 range. Each spectrum was the average over 30
scans.
The X-ray diffraction (“XRD”, X'pert PRO, PANalytical, Almelo, The
Netherlands) was performed on 10mm×10mm×3mm scaffolds by
using the CuKα radiation (λ=1.54Å); the scans were acquired in the
10°–90° 2θ range, with a step size of 0.008° 2θ and a scan step time of
30.48 s.
The porosity P was estimated by measuring the volume, v⁠sc, and the
mass, m⁠sc, of the scaffolds (at least 5 samples for each type) and then
applying the formula:
(1)
where ρ⁠p is the polymer density (1.16g/cm⁠3 for PMMA [20] and 1.10g/
cm⁠3 for PU [21]).
The scaffolds were cut manually to a dimension of
8mm×8mm×3mm. Then, compressive tests were performed at room
temperature on a TA DMA Q800 (TA Instruments, New Castle, DE, USA)
equipped with an 18N load cell; the applied load was increased at a con-
stant rate of 1N/min. For each sample, the force and deflection data ac-
quired by the instrument were converted to engineering stress and strain
values, respectively, and the compressive Young's modulus, E, was cal-
culated as the slope of the stress-strain curve according to the equation
(2)
where ε⁠2 and ε⁠1 are the strain values at two selected points of the
stress-strain curve and σ⁠2 and σ⁠1 are the corresponding stresses. For
each polymer matrix, appropriate portions were considered on the
stress-strain curve in order to analyze the linear elastic behavior. All the
values for E were calculated as means of five measurements (±standard
deviation).
The stability of the scaffolds was tested in common sterilizing me-
dia. Since PMMA is expected to be soluble in ethanol-water solutions
[22], pure ethanol was considered for PMMA-based scaffolds, whereas
a 75% ethanol solution was used for PU-based scaffolds. The scaffolds
were immersed for 4days and the soaking liquid was refreshed once
a day. A standard volume of 50ml was used for 5mm×5mm×3mm
scaffolds. After soaking, the scaffolds were left to dry in ambient condi-
tions, gently rinsed with distilled water and left to dry in ambient con-
ditions again. The effect of soaking was assessed via ESEM observation
and FT-IR analysis.
2.3. Cell culture and viability tests
PMMA and PU supports were sterilized by immersion in 10ml of
100% ethanol or 75% ethanol, respectively, for 24h in a mixing rotator.
They were then washed for 24h with sterile water to get rid of ethanol.
No contamination was detected over the culture period in all samples
tested.
The supports were glued to the bottom of a 12-well plate using 5μL
of THF, and coated with the extracellular matrix component type IV
collagen (Sigma-Aldrich) at a dilution of 150μg/ml in Dulbecco's Phos-
phate Buffered Saline (PBS), for 2h at room temperature on a shaker.
Wells were then filled with RPMI 1640 culture medium additioned of
10% FBS, 100U/ml Penicillin/Streptomycin, 100U/l l-Glutamine (Eu-
roclone), to soak PU and PMMA supports, and left sit for 24h at 37 °C
with 5% CO⁠2.
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Fig. 4. Granulometric curves of the salts used to process the optimized scaffolds: S2 sieved below 1000μm (a) and S3 sieved between 1000μm and 2000μm (b).
Collagen-coated scaffolds (5mm×5mm×5mm cubes) were ob-
served with a Nikon SMZ7457 stereomicroscope (Nikon Instruments Eu-
rope B.V., Italy) to verify the porous architecture after coating.
For immunofluorescence analysis, collagen-coated scaffolds, seeded
with 1×10⁠5 HS5 cells, after 16h were fixed for 15min with 4%
paraformaldehyde, and then stained with DAPI and Cy3-phallodin
1:100 [Millipore]. Confocal imaging was performed by a Nikon A1 con-
focal laser scanning microscope (Nikon Instruments Europe B.V., Italy),
and three-dimensional pictures of scaffold surfaces were obtained by 50
Z series (3μm each), in order to reach around 150μm depth.
The scaffolds were centrally cut and the inner core analyzed. The
confocal serial sections (20 Z series, 1μm each) were processed with Im-
ageJ software to obtain three-dimensional projections. The image ren-
dering was performed by Adobe Photoshop software.
Jurkat cells, a T-acute lymphoblastic leukemia cell line, were grown
in suspension in full RPMI 1640. Human Stromal-5 (HS-5) cells were
seeded on top of the scaffolds at a density of 1×10⁠5 cells/well and al-
lowed to enter inside the pores for 24h. In co-culture experiments, Ju-
rkat cells were added to the HS5-containing wells after 24h at a den-
sity of 4×10⁠5 cells/well [23]. Cell adhesion to the supports was tested
by fixation in 4% paraformaldehyde for 15min at room temperature
and nuclear staining with the DNA binding fluorescent stain 4′,6‑di-
amidino‑2‑phenylindole (DAPI) for 15min at room temperature, and
observation with an inverted Nikon A1 confocal laser scanning micro-
scope [24,25]. For cytotoxicity experiments, 24h after seeding, cells
were additioned with the dual PI3K and mTOR inhibitor PF-04691502
or with DMSO vehicle. Cytotoxicity was assessed both by MTT
(Sigma-Aldrich) and Annexin V analysis. Briefly, 24h after treatment
co-cultured cells were trypsinized, washed in PBS and incubated with
4μl of phycoerythrin (PE)-conju
gated anti-CD5 monoclonal antibody (BD) for 20min at room temper-
ature in the dark, to selectively stain Jurkat cells. To detect apoptosis,
samples were incubated with Annexin V–FITC (Sigma Aldrich) in bind-
ing buffer (10mM HEPES pH7.4, 140mM NaOH, 2.5mM CaCl2) for
15min at room temperature in the dark. Moreover, cells from single cul-
tures were collected, washed with PBS and stained with Annexin V–FITC
in Annexin V binding buffer for 15min at room temperature in the dark.
All samples were then analyzed by flow cytometry with a Coulter Epics
XL MCL equipment. Annexin V positive (Annexin V⁠+) cells are apoptotic
cells.
3. Results and discussion
3.1. Preliminary scaffolds: effect of salt type
In order to investigate the effect of the salt type, three pilot samples
were produced with S1 (scaffold PMMA_S1_1:2), with NHC (scaffold
PMMA_NHC_1:2), and with a 50-50 mixture of S1 and NHC salts (scaf-
fold PMMA_S1+NHC_1:2); to fix the attention on the porogen, PMMA
was consistently used as the matrix and the polymer-to-salt ratio was
fixed to 1:2. As shown in Fig. 1, it should be underlined that the two
salt powders used for these preliminary scaffolds, namely S1 and NHC,
differ not only in chemical composition, but also in grain size and mor-
phology. The S1 particles are indeed cubic (Fig. 1a), whereas the NHC
ones are more irregular and often elongated (Fig. 1b); analogously, the
S1 particles are larger than the NHC counterparts. For comparison, Fig.
1 also includes the micrographs of the sieved S2 and S3 salts used for
the optimized scaffolds.
Since the pores of SCPL scaffolds are the cavities left by the salt
particle removal, the pores in PMMA_S1_1:2 basically preserve a cu-
bic geometry (Fig. 2a), whilst the pores in PMMA_NHC_1:2 are finer
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Fig. 5. Microstructure of the optimized scaffolds: PMMA_S2 (a), PMMA_S3 (b), PU_S2 (c), and PU_S3 (d). Scale bar: 1mm.
Table 2
Porosity (mean value±standard deviation) estimated through Eq. (2) and compressive
modulus at appropriate strain intervals/values for PMMA_based scaffolds and for PU_based
ones.
Scaffold
Porosity
[%] Compressive modulus, E⁠c [kPa]
PMMA
scaffolds
Strain:
0.3–0.7%
PMMA_S2 84.3±1.5 1283±803
PMMA_S3 87.4±3.3 1143±675
PU scaffolds Strain:
0.3–0.7%
Strain:
40%
Strain: 70%
PU_S2 91.3±0.9 29±9 50±6 493±76
PU_S3 82.1±2.3 75±27 150±44 1883±181
and more irregular (Fig. 2b). Obviously, PMMA_S1+NHC_1:2 exhibits
both types of pores (Fig. 2c). The pores in PMMA_S1_1:2 create a con-
tinuous network; the porosity is rich and open, but not perfectly even
throughout the cross section, probably as a consequence of the partial
precipitation of salt during processing. To the contrary, if NHC is used,
the porosity, though rich, is less obviously continuous. Most of all, the
pores induced by NHC are much smaller. The pore size in scaffolds for
cell culturing plays a key role, because pores must be large enough to
support efficient diffusion of nutrients and oxygen for cells; a diameter
of at least 100μm is strictly required to the purpose [26]. This pre-req-
uisite substantially does not permit the use of NHC, since the obtained
pores are too small. However, in view of the addition of the collagen
coating, which is expected to reduce the usable pore size, also the pores
left by S1 particles may be too small, since the average edge length of
the salt grains, which determines the pore size, is about 260μm.
Fig. 6. XRD spectra acquired on PMMA (thin line) and PU (bolt line) scaffolds (with salt
S2).
3.2. Preliminary scaffolds: effect of polymer-to-salt ratio
In order to enrich the porosity and homogenize its distribution, the
polymer-to-salt ratio was modified from 1:2 to 1:3; additionally, the S1
salt was substituted with two common salts whose grain size was larger.
As previously anticipated, for these pilot samples, the new S2 and S3
salts were used as received, without sieving. Fig. 3 compares the three
pilot PMMA scaffolds obtained with S1, S2-NS and S3-NS and with a
polymer-to-salt ratio of 1:3.
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Fig. 7. FT-IR analysis performed on PMMA (a) and on PU (b) systems. In both graphs, black line: original polymer pellet; red line: corresponding scaffold (with salt S2). (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this article.)
The increase in the relative amount of porogen gives place to a
richer porosity (sample PMMA_S1_1:3, Fig. 3a); however, the polymer
struts are still relatively thick, thus suggesting the possibility of modi-
fying the polymer-to-salt ratio further, namely from 1:3 to 1:4. Though
not sieved, the new salts, S2-NS (sample PMMA_S2-NS_1:3, Fig. 3b) and
S3-NS (sample PMMA_S3-NS_1:3, Fig. 3c), are able to imprint larger
pores and they are therefore preferable to S1.
3.3. Optimized scaffolds
3.3.1. Microstructure
On account of the previous results, the final scaffolds were man-
ufactured with a polymer-to-salt ratio of 1:4. Moreover, in order to
control the pore size more closely, the fine-grained and coarse-grained
salts were sieved into two complementary grain size ranges,
namely below 1000μm (salt “S2”) and between 1000 and 2000μm (salt
“S3”). The corresponding granulometric curves, which are reported in
Fig. 4, are mono-modal for both powders, with d(0.5)=604μm for S2
and d(0.5)=1015μm for S3.
In this way, highly porous and well interconnected sponge-like struc-
tures could be achieved both with PMMA and with PU, as shown in
Fig. 5. Regardless of the polymer matrix, the porogen concentration
was indeed high enough to create a well interconnected network thanks
to close geometric packing [27], whereas increasing further the rel-
ative amount of porogen brought about a loss of structural continu-
ity (data not shown) since the polymer was not enough to fill the
space between the salt particles, which impeded the complete devel-
opment of the polymer struts [28]. The improved interconnectivity
with respect to the preliminary samples also depends on the shape
of the S2 and S3 salt particles [27], that is still irregular
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Fig. 8. Stress-strain compressive curves for PMMA-based scaffolds (a) and PU-based ones
(b).
but more spherical with respect to the strictly cubic geometry of S1, as
shown in Fig. 1.
At higher magnification, the PU-based scaffolds exhibit a fine mi-
croporosity and surface roughness, which presumably originate from
the use of DMF and THF to dissolve the polymer. In fact, according to
the contribution by Gorna and Gogolewski [29], DMF works as solvent,
whereas THF works as non-solvent. The difference in their solubility pa-
rameters causes a liquid-induced phase separation that results in the for-
mation of micropores, especially on the walls of the macro-pores left
by the salt particles [29]. As previously mentioned in the Experimental
section, the surface of the present scaffolds has to be coated with colla-
gen, in order to improve the affinity of the polymer substrate with cells
[28,30]. However the intrinsic microporosity and fine irregularity of the
PU struts may play an advantageous role, since it is known from the
literature that the surface roughness of scaffolds enhances attachment,
proliferation and differentiation of cells [31].
With a focus on the macro-pores left by the salt particles, an at-
tempt was made to elaborate the SEM images to measure the poros-
ity and the mean pore size of the scaffolds. Nevertheless, the porosity
of the S2-derived scaffolds is too fine and complicated to allow a re-
liable calculation; also for the S3-derived scaffolds, the intrinsic tridi-
mensionality of the cellular architecture limits the significance of the
image elaboration. In spite of this hindrance, as a demonstration the
image elaboration was completed on the PU_S3 scaffolds, which pos-
sess a mean pore size of 1.12mm (expressed as mean equivalent di
ameter) and an average porosity of 92%. The mean pore size matches
very well the value of d(0.5)=1015μm obtained for the S3 powder
(Fig. 4b).
As an alternative approach, the porosity was calculated from the
mass and volume of the scaffolds. The results are listed in Table 2.
For PMMA-based scaffolds, the mean porosity is similar for both
porogens, whereas the mean porosity of PU_S2 is sensibly higher than
that of PU_S3. This is in agreement with the trends observed by Sin et
al., who investigated PU-based scaffolds produced by SCPL with and
without an additional centrifugal step [28].
3.3.2. X-ray diffraction
The XRD spectra acquired on the scaffolds should be considered with
caution, since the optimal geometric conditions for diffraction were not
respected in every single point of the nominal surface of the samples
due to the complicated three-dimensional architecture of cellular mate-
rials. However, as exemplified in Fig. 6, the polymer matrix was sub-
stantially amorphous both in PMMA- and PU-based scaffolds, which is
coherent with the limited tendency to crystallize of porous systems with
respected to bulk counterparts that has been recently reported in the lit-
erature for PLA-based SCPL scaffolds [13]. No peaks could be attributed
to the residual presence of porogen (NaCl), thus confirming the achieve-
ment of a well interconnected and open porosity and, at the same time,
the effectiveness of the wash-out step. Analogous diffractograms were
collected both for S2 and S3 salts (data not shown).
3.3.3. Infrared spectroscopy
In order to check the possible effects of processing on the polymer
structure, the FT-IR analysis was performed on the original polymer pel-
lets, to define a benchmark (black lines in Fig. 7), and on the corre-
sponding scaffolds (red lines). For clarity reasons, Fig. 7 proposes the
spectra acquired on the scaffolds processed with the S2 particles, but
those with S3 are equivalent. For PMMA, the trend is qualitatively the
same for the original polymer and for the scaffold, even if the peaks
are more intense and defined for the former than for the latter. The dif-
ferences are more detectable in the fingerprint range between 987cm⁠−1
and 810cm⁠−1. The attribution of the single peaks in this area is not
straightforward, but the band at 962cm⁠−1 can be assigned to the C
CH⁠3 bending [32], which is likely to be affected by the solvent action
during processing. To the contrary, the PU spectra are identical before
and after processing, thus proving that the polymer structure was not
altered by the manufacturing process.
3.3.4. Mechanical properties
Even if the present scaffolds are not intended for load bearing, their
mechanical properties are relevant, because the scaffolds must be easy
to handle. Moreover, it is known from the literature that, in principle,
the stiffness of a scaffold influences inter-/intracellular signaling, cell
growth and motility, and response to stimulation or inhibition [3].
Representative stress-strain graphs are reported in Fig. 8a, for
PMMA-based scaffolds, and in Fig. 8b, for PU-based ones. Since PMMA
is a relatively stiff polymer (tensile modulus E⁠p:
295000psi≈2034.0MPa [20]) whereas PU is a relatively flexible one
(tensile modulus (at 50% strain) E⁠p: 3.1MPa [21]), also the compressive
behavior of the corresponding scaffolds is sensibly different and there-
fore the stress-strain graphs are not directly superimposing; in more de-
tail, being the stress the same (up to about 300kPa), the strains achieved
during testing are much higher for the PU-based scaffolds than for the
PMMA-based ones.
Generally speaking, if the PMMA-based scaffolds are considered,
the stress-strain graphs of the PMMA_S2 samples have a first, short
linear segment, followed by a second, steeper segment for strains ex
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Fig. 9. FT-IR analysis performed on PMMA (a) and on PU (b) scaffolds to assess the effect of sterilizing media. In both graphs, black line: original scaffold; blue line: scaffold soaked in
sterilizing medium for 4days (scaffolds produced with salt S2). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
ceeding 1%. Even if the slope of the stress-strain curves for the PM-
MA_S3 scaffolds is almost constant over a wider range, up to a strain of
about 10%, for comparison E⁠c was calculated in the 0.3–0.7% strain in-
terval for all the PMMA-based scaffolds.
The compressive behavior of the PU-based scaffolds remains sub-
stantially linear up to a strain of 30%, then the slope of the stress-strain
curve progressively increases, especially for the PU_S2 scaffolds; be-
ing the strain the same, the stress is indeed systematically higher for
the PU_S2 scaffolds than for the PU_S3 ones. On account of the high
deformability of the PU-based scaffolds, E⁠c was calculated over the
0.3–0.7% strain interval in order to have a term of comparison with the
PMMA-based scaffolds, but it was also calculated at 40% and at 70% of
strain (for the latter two values, E⁠c was determined as the tangent slope).
All the results for E⁠c calculations are summarized in Table 2. If
the values in Table 2 are considered, it is apparent that, coherently
with the superior stiffness of PMMA with respect to PU, E⁠c in the
0.3–0.7% strain interval is higher for the PMMA-based scaffolds than
for the PU counterparts. The high standard deviation signifies that
the data in Table 2 are spread over a wide range, however E⁠c is, on aver-
age, higher for the PMMA_S2 scaffolds than for the PMMA_S3 ones. This
is likely due to the different porosity, that is indeed lower for the PM-
MA_S2 scaffolds than for the PMMA_S3 ones, as previously seen in the
same Table 2. Analogously, if the PU-based scaffolds are compared, E⁠c is
relevantly higher for the PU_S3 scaffolds than for the PU_S2 ones, again
as a result of the difference in porosity observed for these scaffolds. A
similar result has already been reported in the literature for PU-based
SCPL scaffolds designed for cardiac tissue engineering [28].
From the graphs in Fig. 8 as well as from the results in Table
2, it is clear that the values calculated for E⁠c are influenced by the
applied load, on the one hand, and by the scaffold's features, espe-
cially the polymer type and the porosity, on the other. Independently
of the specific scaffold type, E⁠c depends indeed on the applied load
and consequent strain, with a trend that implies at first a plateau and
then a progressive rise, that becomes very steep for high strain val-
ues. As a matter of fact, the initial elastic deformation of the struts
is followed by subsequent folding, which causes the scaffold to pack
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Fig. 10. HS-5 cells were grown associated to collagen-coated composites. DAPI staining of cells seeded on PU (left panel) or PMMA (right panel) 3D-supports indicates that cell nuclei
have a normal and regular shape, characteristic of healthy cells. A representative image of each support is shown. Overlapping results were obtained for both pore sizes.
Fig. 11. Porous architecture before and after collagen coating. (a) PU_S2 scaffold; (b) PMMA_ S3 scaffold. Tested samples: 5mm×5mm×5mm cubes. Low magnification images: stan-
dard zoom 0.67; high magnification images: standard zoom 1.
and behave like a “massive” (i.e. not porous) bulk material, with a re-
sulting increase in E⁠c [28].
If the effect of the polymer type and of the porosity is considered,
according to the models proposed by Gibson and Ashby [33] to describe
the linear elastic behavior of three-dimensional cellular materials un-
der compression, the compressive modulus E⁠sc of an open-cell scaffold
should depend on the Young's modulus of the polymer struts, E⁠p, and on
the relative density ??⁠sc/??⁠p as:
(3)
where C is a constant whose value is usually assumed to be 1 [33].
For the present scaffolds, ??⁠p is 1.16g/cm⁠3 for PMMA [20] and 1.10g/
cm⁠3 for PU [21], whereas the densities of the corresponding scaffolds
??⁠sc are directly associated to the porosity values listed in Table 2. The
previsional compressive modulus should be therefore 50,070kPa for
PMMA_S2, 32,664kPa for PMMA_S3, 24kPa for PU_S2 and 99kPa for
PU_S3. If compared to the results in Table 2, the obtained values are in
good agreement with the experimental ones for PU-based scaffolds, but
not for PMMA-based ones.
Jo et al. [34] proposed specific models to describe the compressive
behavior of PMMA open-cell foams and they calculated the compressive
modulus as:
(4)
where C⁠1 =0.2515, C⁠2 =0.2073, C⁠3 =0.06409, C⁠4 =0.008801, and
C⁠5 =0.0004533 [34]. For PMMA open-cell foams, the constant C⁠0 was
experimentally determined to be 1.88 [34]. Strictly speaking, Eq. (4)
should be applied for 0.2<??⁠sc/??⁠p <0.8, whereas ??⁠sc/??⁠p is here
about 0.157 for PMMA_S2 and 0.127 for PMMA_S3, which means that
the present scaffolds are slightly more porous than the typical cellu-
lar materials encompassed by the model of Eq. (4). However, as an in-
dication, the previsional compressive modulus E⁠sc calculated according
to Eq. (4) should be 16,690kPa for PMMA_S2 and 11,795kPa for PM-
MA_S3. Again, the calculated values overestimate the real ones.
Since the predicted values for PMMA scaffolds deviate from the ex-
perimental data for both models, it is plausible that the problem de-
rives from the input data. In fact, the analytical results are strongly
affected by the value of E⁠p used to calculate them. As a first approx-
imation, the (tensile) elastic modulus of the pristine polymer was in-
troduced for E⁠p both in Eq. (3) and in Eq. (4). However, as remarked
by Gibson and Ashby [33], the real value of the elastic modulus of
the scaffold matrix is rarely known with precision, as it depends on
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Fig. 12. Scaffold colonization by HS5 cells. PU and PMMA scaffolds, seeded with HS5 cells, were treated for immunofluorescence analysis. DAPI and Cy3-phallodin staining reveals the
nuclei in blue and the actin cytoskeleton in red, respectively. A) Representative three-dimensional pictures of 150μm depth of TOP and BOTTOM sides of PU and PMMA scaffolds show
the cell distribution under the scaffold surfaces. B) Representative three-dimensional projections of the middle part (CENTRAL) are shown for both the scaffolds. Scale bar=20μm for all
images. Triple magnification of one cell is shown in white squares to monitor cell morphology. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
the degree of polymer-chain alignment, on chemical changes brought
about by the fabrication process, on the possible aging and/or oxida-
tion of the polymer and other uncontrolled phenomena [33]. For the
PMMA-based scaffolds considered here, it is likely that some changes oc-
curred during processing as supported by the FT-IR analysis, thus mod-
ifying the elastic modulus of the scaffold's matrix with respect to the
unprocessed polymer. Nonetheless, it is worth noting that, as expected,
the PMMA-based scaffolds are sensibly stiffer than the PU-based ones.
Additionally, all the produced scaffolds can be easily handled without
neither breaking nor collapsing.
3.3.5. Stability in sterilizing media
Before seeding with cells, the scaffolds must be sterilized by im-
mersing them in an appropriate liquid and then exposing them to UV
light. In order to test their chemical stability, both PMMA-based scaf-
folds and PU-based ones were conditioned in pure ethanol and in 75%
ethanol for four days, respectively. The prolonged soaking time, which
was obviously longer than the real one (that is typically in the or-
der of minutes), was addressed to amplify the effect of the sterilizing
medium. According to the ESEM observation, the original porous ar-
chitecture was not altered in any of the analyzed scaffolds (data not
reported). FT-IR spectra were also acquired on the scaffolds to inves-
tigate more closely the effect of the sterilizing media on the poly-
mer structure. As a term of comparison, Fig. 9 shows the overlays of
the spectra acquired on the pristine (not-soaked) scaffolds and those
acquired after soaking. For the sake of brevity, Fig. 9 includes the
spectra acquired on the scaffolds produced with the S2 particles only,
but those with S3 are analogous. Since no significative changes
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Fig. 13. The apoptotic Jurkat cells sub-population was identified by dual staining with an
anti-CD5+ antibody to detect Jurkat cells, together with Annexin V to detect apoptosis,
as described in Materials and Methods. Overlapping results were obtained for both pore
sizes.
were detected in the respective spectra, pre- and post-immersion, even
after soaking for 4days, it is reasonable to conclude that the immersion
in sterilizing media is not modifying the structure of the polymer ma-
trices, provided that pure ethanol is used for PMMA-based scaffolds and
75% ethanol is used instead for PU-based ones.
3.4. Effect of scaffolds on cell growth and viability
Next, we wanted to investigate whether PMMA and PU supports can
represent valuable tools to mimic the in vivo 3D context in which stro-
mal cells proliferate in the bone marrow (BM). Human HS-5 stromal
cells were seeded on top of the collagen-coated scaffolds and left to ad-
here and grow for 48h. Nuclear staining with DAPI displayed very reg-
ularly shaped nuclei (Fig. 10), suggesting that both PMMA and PU sup-
ports do not affect cell adhesion and proliferation.
As shown in Fig. 11, the collagen coating procedure did not alter
the porous architecture and the pore network remained open and inter-
connected. To check whether cells could effectively migrate inside the
scaffold, immunofluorescence analysis was also performed. Confocal mi-
croscopy allowed to scan both sides of the scaffolds in depth. Fig. 12a
clearly shows that cells not only seed on top of the scaffolds, but they
also enter into the interconnected pore structure with a similar distri-
bution into both PU and PMMA scaffolds. As expected, PU displayed
a blue autofluorescence. Additionally, the analysis of the inner part of
both PU and PMMA supports demonstrated the complete colonization
by HS5 cells. What's more important, staining with Cy3-phalloidin made
it possible not only to detect the expected fibroblast-like morphology,
but also to confirm the presence of the very regular cytoskeleton, with
large bundles of stress fibers as well as focal adhesions where cells at-
tach to the scaffold (Fig. 12b, white squares).
The cytotoxic drug PF-04691502 is a dual phosphoinositide 3-ki-
nase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor,
which has shown good cytotoxic activity towards primary effusion
lymphoma cells (PEL) [35,36], but very low toxicity towards normal
T and B lymphocytes, and is currently under evaluation in pre-clini-
cal studies for cancer therapy. Here, we asked whether to grow stro-
mal cells in adhesion on collagen-coated 3D supports, such as the PU
or PMMA scaffolds described above, might stimulate their production
of pro-survival factors and therefore help mimicking the physiologi-
cal BM background. To do this, first we tested the viability of the
Jurkat cell line upon addition for 24h of vehicle or PF-04691502 at
a concentration of 500nM, either grown as single culture, in co-cul-
ture with HS-5 cells, or in co-culture with HS-5 cells previously seeded
onto PMMA or PU scaffolds. Jurkat cell death in response to drug
treatment in all the above conditions was evaluated by flow cytometry.
The results are very clear: Jurkat cells as single culture displayed the ex-
pected 20% increased mortality following addition of the cytotoxic drug
PF-04691502 to the growth medium, compared to their untreated coun-
terpart (Fig. 13).
Conversely, the drug was not able to trigger HS-5 cells apoptosis,
showing that this cell line is not sensitive to this molecule and should
not therefore interfere with the cytotoxicity assay. However, when Ju-
rkat and HS-5 cells were co-cultured, apoptosis was largely prevented
both in basal culture condition and upon addition of the drug. This re-
sult was not unexpected, as stromal cells are indeed known to mimic,
to some extent, the protective bone marrow microenvironment on can-
cer cells. Here, their pro-survival effect on Jurkat cells was easily de-
tectable. Next, cell viability was monitored in cell co-cultures grown in
the presence of either PMMA- or PU-based scaffolds. The results were
comparable to that obtained in the absence of supports both in un-
treated and in PF-04691502-treated Jurkat/HS5 co-cultures. Interest-
ingly, the result shows that the bone-marrow-mimicking, protective ef-
fect of stromal cells on Jurkat cancer cells is maintained, as the drug
cytotoxicity is almost abrogated, when HS-5 cells are grown associated
to the scaffolds. Therefore these devices can be very useful to test drug
efficacy in a 3D-like microenvironment known to exert pro-survival ef-
fects on cancer cells.
4. Conclusions
The BM niche is the microenvironment where hematopoietic stem
cells proliferate whilst keeping their cell state, and it is known to offer a
protective setting for malignant cell survival and proliferation. The pur-
pose of the present research was to produce 3D scaffolds that, mimick-
ing the BM niche, could provide appropriate in vitro conditions to even-
tually test new treatments against hematological malignancies.
The production of scaffolds by means of SCPL was relatively easy
and the appropriate choice of the polymer type, of the polymer-to-salt
ratio and of the salt grain size allowed to control the porosity and the
pore size, with immediate consequences on the mechanical properties
of the scaffolds, whose elastic modulus under compression varied in-
dicatively from 29kPa for flexible PU-based samples (porosity: 91%) to
1283kPa for rigid PMMA-based samples (porosity: 84%). According to
the preliminary assays shown above, stromal cells not only adhere to
the supports, upon collagen-coating, but they also retain their protec-
tive and pro-survival action towards co-cultured cancer cells, therefore
preventing the cytotoxic effect of the drug. As it is very well known
that efficacy of drug treatment can be mitigated, if not abolished, by the
emergence of resistance mechanisms supported by components of the
BM niche, it has become mandatory to test drug efficacy in pre-clinical
settings that can reproduce as closely as possible the BM microenviron-
ment. It is therefore possible to conclude that the SCPL technique, orig-
inally intended to produce scaffolds for bone tissue repair, can be suc-
cessfully extended to the achievement of improved three-dimensional
supports for stromal cells to mimic the BM niche.
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